Literature DB >> 29147880

Targeted Physician Education and Standardizing Documentation Improves Documented Reporting with Inflammatory Bowel Disease Quality Measures in a Large Academic and Private Practice.

Joseph D Feuerstein1, Konstantinos Papamichael2, Sara Popejoy3, Adam Nadelson4, Jeffrey J Lewandowski2, Kathy Geissler3, Manuel Martinez-Vazquez5, Daniel A Leffler2, Kim Ariyabuddhiphongs6, Chandrashekhar Thukral3,7, Adam S Cheifetz2.   

Abstract

BACKGROUND: Prior studies have shown poor compliance with quality measures for IBD at academic and private practices. We sought to provide focused interventions to improve compliance and documentation with the IBD measures.
METHODS: Two centers, academic practice (AP) and private practice (PP), initially reviewed their compliance with eight established IBD quality measures in consecutive charts. A multi-faceted intervention was developed to improve awareness and documentation of these measures. The initial data and the quality measures were reviewed at a group meeting. Following this, a handout summarizing the measures was placed in each exam room. The AP added a new screen to the EHR that summarized the relevant IBD history, while the PP added a new template that was filled out and imported into the charts. Three months after this intervention, charts were reviewed for compliance with the measures.
RESULTS: The intervention cohort consisted of 768 patients (AP = 569/PP = 199) compared to the initial cohort of 566 patients (AP = 367/PP = 199). Improvement was seen throughout all measures compared to the initial cohort. The AP reported compliance with all relevant measures in 21% and the PP in 60% compared to 7 and 10% in the initial cohort. PP had ≥ 75% compliance with every measure, of which only assessment for bone loss and pneumococcal vaccination was under 80%. In contrast, the AP compliance ranged from 35 to 100% with assessment for bone loss, influenza, and pneumococcal vaccination scoring lowest.
CONCLUSION: Our study demonstrates that focused low-cost interventions can significantly improve compliance with IBD quality measures in different practice settings.

Entities:  

Keywords:  Crohn’s disease; Guidelines; Healthcare quality; Inflammatory bowel disease; Outcomes; Quality measures; Ulcerative colitis

Mesh:

Year:  2017        PMID: 29147880     DOI: 10.1007/s10620-017-4845-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy.

Authors:  Byron P Vaughn; Glen A Doherty; Shiva Gautam; Alan C Moss; Adam S Cheifetz
Journal:  Inflamm Bowel Dis       Date:  2011-09-26       Impact factor: 5.325

2.  The future of quality measurement for improvement and accountability.

Authors:  Patrick H Conway; Farzad Mostashari; Carolyn Clancy
Journal:  JAMA       Date:  2013-06-05       Impact factor: 56.272

3.  A quality improvement project significantly increased the vaccination rate for immunosuppressed patients with IBD.

Authors:  Siddhartha Parker; Laura Chambers White; Chad Spangler; Jessica Rosenblum; Shannon Sweeney; Emily Homan; Steven P Bensen; L Campbell Levy; Maria Conception C Dragnev; Kristen Moskalenko-Locke; Pamela Rich; Corey A Siegel
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

4.  Incorporating quality measurement and improvement into a gastroenterology practice.

Authors:  Irving M Pike; Joseph Vicari
Journal:  Am J Gastroenterol       Date:  2010-02       Impact factor: 10.864

5.  Documented compliance with inflammatory bowel disease quality measures is poor.

Authors:  Joseph D Feuerstein; Jeffrey J Lewandowski; Manuel Martinez-Vazquez; Daniel A Leffler; Adam S Cheifetz
Journal:  Dig Dis Sci       Date:  2014-10-14       Impact factor: 3.199

Review 6.  Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review.

Authors:  K T Park; Dorsey Bass
Journal:  Inflamm Bowel Dis       Date:  2010-11-04       Impact factor: 5.325

7.  A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases.

Authors:  Welmoed K van Deen; Martijn G H van Oijen; Kelly D Myers; Adriana Centeno; William Howard; Jennifer M Choi; Bennett E Roth; Erin M McLaughlin; Daniel Hollander; Belinda Wong-Swanson; Jonathan Sack; Michael K Ong; Christina Y Ha; Eric Esrailian; Daniel W Hommes
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

8.  How to Develop the Medical Neighborhood.

Authors:  Joseph D Feuerstein; Victoria Sheppard; Adam S Cheifetz; Kim Ariyabuddhiphongs
Journal:  J Med Syst       Date:  2016-07-22       Impact factor: 4.460

9.  Poor Documentation of Inflammatory Bowel Disease Quality Measures in Academic, Community, and Private Practice.

Authors:  Joseph D Feuerstein; Natalia E Castillo; Sana S Siddique; Jeffrey J Lewandowski; Kathy Geissler; Manuel Martinez-Vazquez; Chandrashekhar Thukral; Daniel A Leffler; Adam S Cheifetz
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 11.382

10.  Ten challenges in improving quality in healthcare: lessons from the Health Foundation's programme evaluations and relevant literature.

Authors:  Mary Dixon-Woods; Sarah McNicol; Graham Martin
Journal:  BMJ Qual Saf       Date:  2012-04-28       Impact factor: 7.035

View more
  1 in total

1.  Sustained Improvement in Inflammatory Bowel Disease Quality Measures Using an Electronic Health Record Intervention.

Authors:  Andrew Bensinger; Farra Wilson; Patrick Green; Richard Bloomfeld; Ajay Dharod
Journal:  Appl Clin Inform       Date:  2019-12-04       Impact factor: 2.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.